{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-045671","form_type":"8-K","ticker":null,"cik":"0001597553","company_name":"Sage Therapeutics, Inc.","filed_at":"2025-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.119373+00:00","generated_at":"2026-05-25T14:02:21.835003+00:00","sec_items":["5.02","8.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Sage Therapeutics CMO Laura Gault resigns, effective March 21; CSO Quirk to lead clinical programs on interim basis","bullets":["Laura Gault, M.D., Ph.D. resigns as CMO effective March 21, 2025, to pursue a new opportunity.","Resignation is not due to any disagreement with Sage Therapeutics.","Mike Quirk, Ph.D., current CSO, will assume interim oversight of clinical development programs."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-045671","json":"https://secwatch.observer/filing/0001193125-25-045671.json","markdown":"https://secwatch.observer/filing/0001193125-25-045671.md","text":"https://secwatch.observer/filing/0001193125-25-045671.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1597553/000119312525045671/0001193125-25-045671-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1597553/000119312525045671/d939383d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T14:02:21.835003+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ebbe84a406","claim":"Laura Gault resigned as Chief Medical Officer at Sage Therapeutics, Inc..","evidence_excerpt":"On March 3, 2025, Laura Gault, M.D., Ph.D. notified Sage Therapeutics, Inc. (the “Company”) of her decision to resign as Chief Medical Officer of the Company, effective March 21, 2025, to pursue a new opportunity.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1597553/000119312525045671/0001193125-25-045671-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Medical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}